Fc Engineering Strategies to Advance IgA Antibodies as Therapeutic Agents

Fc Engineering Strategies to Advance IgA Antibodies as Therapeutic Agents

In the past three decades, a great interest has arisen in the use of immunoglobulins as therapeutic agents. In particular, since the approval of the first monoclonal antibody Rituximab for B cell malignancies, the progress in the antibody-related therapeutic agents has been incremental. Therapeutic...

Full description

Bibliographic Details
Main Authors:	Geert van Tetering, Mitchell Evers, Chilam Chan, Marjolein Stip, Jeanette Leusen
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Series:	Antibodies
Subjects:	IgA engineering glycosylation half-life FcαRI FcRn
Online Access:	https://www.mdpi.com/2073-4468/9/4/70

Similar Items

Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn in vitro and in vivo
by: Simone Mester, et al.
Published: (2021-01-01)

The Functional Role of IgA in the IgM/IgA-Enriched Immunoglobulin Preparation Trimodulin
by: Fabian Bohländer, et al.
Published: (2021-12-01)

Anti-FcαRI Monoclonal Antibodies Resolve IgA Autoantibody-Mediated Disease
by: Amelie Bos, et al.
Published: (2022-03-01)

Harnessing Fc/FcRn Affinity Data from Patents with Different Machine Learning Methods
by: Christophe Dumet, et al.
Published: (2023-03-01)

Trafficking analyses of FcRn and IgG ligand in the post-Brambell era
by: E. Sally eWard, et al.
Published: (2015-07-01)

IgG subclasses and allotypes: from structure to effector functions
by: Gestur eVidarsson, et al.
Published: (2014-10-01)

FcRn Expression in Wildtype Mice, Transgenic Mice, and in Human Tissues
by: Tommy Li, et al.
Published: (2018-10-01)

Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-life
by: Brian C. Mackness, et al.
Published: (2019-10-01)

Fully human monoclonal antibody inhibitors of the neonatal Fc receptor (FcRn) reduce circulating IgG in nonhuman primates
by: Andrew E Nixon, et al.
Published: (2015-04-01)

The Dual Targeting of FcRn and FcγRs via Monomeric Fc Fragments Results in Strong Inhibition of IgG-Dependent Autoimmune Pathologies
by: Céline Monnet, et al.
Published: (2021-08-01)

The influence of antibody engineering on Fc conformation and Fc receptor binding properties: Analysis of FcRn-binding engineered antibodies and an Fc fusion protein
by: Takuo Suzuki, et al.
Published: (2021-01-01)

Clinical Significance of Serum Albumin and Implications of FcRn Inhibitor Treatment in IgG-Mediated Autoimmune Disorders
by: E. Sally Ward, et al.
Published: (2022-06-01)

Selection of IgG variants with increased FcRn binding using random and directed mutagenesis: impact on effector functions
by: Céline eMonnet, et al.
Published: (2015-02-01)

Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro
by: Omar S. Qureshi, et al.
Published: (2024-12-01)

The contribution of cell surface FcRn in monoclonal antibody serum uptake from the intestine in suckling rat pups
by: Philip R Cooper, et al.
Published: (2014-10-01)

Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model
by: Miriam Manook, et al.
Published: (2021-06-01)

Fcα Receptor-1-Activated Monocytes Promote B Lymphocyte Migration and IgA Isotype Switching
by: Amélie V. Bos, et al.
Published: (2022-09-01)

Megalin Orchestrates FcRn Endocytosis and Trafficking
by: Eileen Dahlke, et al.
Published: (2022-12-01)

Roles of FcRn in Antigen-Presenting Cells during Autoimmunity and a Clinical Evaluation of Efgartigimod as an FcRn Blocker
by: Yihan Zhou, et al.
Published: (2023-06-01)

Human FcRn can mediate the transport across intestinal mucosal barrier and prolong the half-life of rabbit IgG in vivo
by: Guangchang Pang, et al.
Published: (2015-06-01)

The role of FcRn in antigen presentation
by: Kristi eBaker, et al.
Published: (2014-08-01)

FcRN receptor antagonists in the management of myasthenia gravis
by: Vinaya Bhandari, et al.
Published: (2023-08-01)

Advances in therapeutic Fc engineering - modulation of IgG associated effector functions and serum half-life
by: Abhishek Saxena, et al.
Published: (2016-12-01)

The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic Cancer
by: Justin Thomas, et al.
Published: (2022-06-01)

Evidence for the Role of a Second Fc-Binding Receptor in Placental IgG Transfer in Nonhuman Primates
by: Yvonne J. Rosenberg, et al.
Published: (2023-04-01)

Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins
by: Liming Liu
Published: (2017-04-01)

Enhanced immunogenic potential of cancer immunotherapy antibodies in human IgG1 transgenic mice
by: Jerome Egli, et al.
Published: (2022-12-01)

Opinion: There’s been a flaw in our thinking.
by: Clark Lawrence Anderson
Published: (2014-10-01)

Monoclonal Antibody Engineering and Design to Modulate FcRn Activities: A Comprehensive Review
by: Yanis Ramdani, et al.
Published: (2022-08-01)

Heparin chromatography as an in vitro predictor for antibody clearance rate through pinocytosis
by: Thomas E. Kraft, et al.
Published: (2020-01-01)

IgA2 immune complexes selectively promote inflammation by human CD103+ dendritic cells
by: Lynn Mes, et al.
Published: (2023-03-01)

Human FcRn Is a Two-in-One Attachment-Uncoating Receptor for Echovirus 18
by: Xiangpeng Chen, et al.
Published: (2022-08-01)

Tissues Expression, Polymorphisms Identification of FcRn Gene and Its Relationship with Serum Classical Swine Fever Virus Antibody Level in Pigs
by: Liu Yang, et al.
Published: (2012-08-01)

The Neonatal Fc Receptor (FcRn): A Misnomer?
by: Michal Pyzik, et al.
Published: (2019-07-01)

Regulation of immune responses by the neonatal Fc receptor and its therapeutic implications
by: Timo eRath, et al.
Published: (2015-01-01)

Functional humanization of immunoglobulin heavy constant gamma 1 Fc domain human FCGRT transgenic mice
by: Benjamin E. Low, et al.
Published: (2020-01-01)

Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG
by: Arianne M. Brandsma, et al.
Published: (2019-04-01)

Serum immunoglobulin or albumin binding single-domain antibodies that enable tailored half-life extension of biologics in multiple animal species
by: Michiel M. Harmsen, et al.
Published: (2024-01-01)

Antibodies and their receptors: different potential roles in mucosal defence
by: Rachel eHorton, et al.
Published: (2013-07-01)

Oral Fc-Coupled Preproinsulin Achieves Systemic and Thymic Delivery Through the Neonatal Fc Receptor and Partially Delays Autoimmune Diabetes
by: Noémie Corcos, et al.
Published: (2021-08-01)